Karolinne Rocha, MD
Ophthalmology · Charleston, SCNPI 1699098053
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $442,180 of the $552,032 with a category attached, or 80.1%. 25 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 54.2% of the total. Reporting peaked in 2019 at $133,203 and has fallen 53.0% since, to $62,656 in 2025. Among ophthalmology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 590 payments — averaging $935.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$299K
- AbbVie$74K
- Bausch & Lomb Americas Inc.$66K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$54K
- Alcon$16K
- Dompe US, Inc.$15K
- plus $28K from 19 others
Across 23 payments — averaging $10,757 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson Surgical Vision, Inc.$163K
- Alcon Research LLC$37K
- Bausch Health US, LLC$30K
- Bausch & Lomb Americas Inc.$18K
What the payments were for
- Consulting fees$442,18080%
- Speaking & faculty fees$68,58812%
- Travel & lodging$19,8994%
- Food & beverage$21,3654%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 212 | $299,160 |
| AbbVie(2 entities) | 115 | $73,885 |
| Bausch & Lomb Americas Inc. | 91 | $66,210 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 48 | $53,857 |
| Alcon | 26 | $16,243 |
| Dompe US, Inc. | 14 | $14,604 |
| Rayner Intraocular Lenses Limited | 4 | $5,331 |
| Tarsus Pharmaceuticals, Inc. | 12 | $4,774 |
| Novartis | 9 | $2,498 |
| Carl Zeiss Meditec, Inc. | 6 | $2,456 |
| Alcon Research LLC | 6 | $2,161 |
| Oculus, Inc. | 1 | $1,500 |
| Glaukos Corporation | 3 | $1,496 |
| Omeros Corporation | 7 | $1,443 |
| Sun Pharmaceutical Industries Inc. | 13 | $1,257 |
| Kala Pharmaceuticals, Inc. | 2 | $1,250 |
| Hoya Surgical Optics, Inc | 1 | $1,250 |
| Lensar, Inc. | 1 | $700 |
| Johnson & Johnson Vision Care, Inc. | 5 | $697 |
| Carl Zeiss Meditec USA, Inc. | 2 | $372 |
| Harrow Eye, LLC | 4 | $367 |
| Biotissue Holdings Inc. | 3 | $248 |
| Ocular Therapeutix, Inc. | 1 | $105 |
| Recordati_rare_diseases_inc. | 2 | $89 |
| Shire North American Group Inc | 2 | $81 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Compact Intuitiv$115,408
- IFS ADVANCED FEMTOSEC LASER$115,408
- Catalys Laser System$61,140
- Tecnis IOL$60,586
- COMPACT INTUITIV Phacofragmentation System$52,888
- Tecnis Toric 1-piece IOL$28,222
- Tecnis Multifocal Family of 1-piece IOLS$24,868
- VUITY$24,168
- Tecnis Symfony IOL$23,730
- STELLARIS ELITE$21,356
- ENVISTA TORIC$21,315
- Tecnis Simplicity$21,184
- enVista MX60 IOL$21,086
- Tecnis 1-piece IOL$19,844
- ENVISTA$14,754
- enVista Aspire IOL$14,701
- Crystalens Accommodating IOL (AT-52AO)$12,666
- TENEO$12,151
- Trulign IOL$12,056
- Tecnis 3-piece IOL$11,852
How this compares
$552,032 in reported general payments places this provider in the 95th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 92 | $116,741 |
| Cyclosporine | 109 | $56,126 |
| XiidraLifitegrast | 48 | $39,538 |
| Restasis MultidoseCyclosporine | 45 | $32,879 |
| CequaCyclosporine | 34 | $21,462 |
| MieboPerfluorohexyloctane/Pf | 16 | $12,598 |
| Prednisolone Acetate | 208 | $11,132 |
| LotemaxLoteprednol Etabonate | 28 | $9,606 |
| Lotemax SmLoteprednol Etabonate | 22 | $5,672 |
| ValacyclovirValacyclovir Hcl | 61 | $3,531 |
| Loteprednol Etabonate | 14 | $3,075 |
| Fluorometholone | 20 | $1,372 |
| MoxifloxacinMoxifloxacin Hcl | 54 | $1,062 |
| Brimonidine Tartrate | 11 | $953 |
| Doxycycline Hyclate | 49 | $933 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Restasis Multidose | $73,885 | $149,620137 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $66,210 | $52,13664 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $1,257 | $21,46234 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLotemax, Lotemax Sm, Loteprednol Etabonate | $53,857 | $18,35364 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 293 ophthalmology providers in South Carolina.
Other ophthalmology in Charleston
- Drew DicksonCharleston$53K
- Mona CamacciCharleston$26K
- Cole MillikenCharleston$17K
- Daniel AlfaroCharleston$15K
- Karen FernandezCharleston$13K
- John KerrisonCharleston$12K
- Eric JablonCharleston$12K
- Marion WilsonCharleston$9K
- Michael JohnsonCharleston$9K
- Berdine BurgerCharleston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.